Back to Search
AMELIA MELLOR, DO
DO
Student in an Organized Health Care Education/Training Program
NPI: 1417659020Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
PMID 19366986·Blood·2009
7-preclinical
Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria.
PMID 19000912·Int J Parasitol·2009
7-preclinical
T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase.
PMID 19031026·Handb Exp Pharmacol·2009
6-review
Infectious tolerance via the consumption of essential amino acids and mTOR signaling.
PMID 19567830·Proc Natl Acad Sci U S A·2009
7-preclinical
IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.
PMID 19635913·J Immunol·2009
4-observational
Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.
PMID 19208362·Hum Immunol·2009
7-preclinical
IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.
PMID 19218483·J Leukoc Biol·2009
7-preclinical
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis.
PMID 19505881·Gut·2009
7-preclinical
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation.
PMID 18436652·Proc Natl Acad Sci U S A·2008
7-preclinical
Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis.
PMID 18426872·Infect Immun·2008
7-preclinical
Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
PMID 18952840·Proc Natl Acad Sci U S A·2008
7-preclinical
Creating immune privilege: active local suppression that benefits friends, but protects foes.
PMID 18064049·Nat Rev Immunol·2008
6-review
Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.
PMID 18077788·Blood·2008
7-preclinical
Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury.
PMID 18480171·Am J Physiol Renal Physiol·2008
7-preclinical
A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
PMID 18026137·Oncogene·2008
7-preclinical
Paediatric thoracic damage control resuscitation for ballistic injury: a case report.
PMID 18619172·J R Army Med Corps·2007
5-case
Intra-osseous access (EZ-IO) for resuscitation: UK military combat experience.
PMID 18619171·J R Army Med Corps·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10175 GATEWAY BLVD W STE 140
EL PASO, TX 79925 - Phone
- (915) 283-3953
Quick Facts
- NPI
- 1417659020
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile